D-0090-2023 Class II Terminated

Recalled by Hikma Pharmaceuticals USA Inc. — Cherry Hill, NJ

Recall Details

Product Type
Drugs
Report Date
January 4, 2023
Initiation Date
December 16, 2022
Termination Date
December 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,760 vials

Product Description

Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH, Germany, Distributed by Hikma Berkeley Heights, NJ 07922, NDC 0143-9299-01

Reason for Recall

Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

Distribution Pattern

USA Nationwide

Code Information

Lot#: BQ0006, Exp 08/2023